)
Medmix (MEDX) investor relations material
Medmix H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Gross profit and adjusted EBITDA margin exceeded guidance despite a 4.8% organic revenue decline, with gross profit up to CHF 161.9 million and gross margin at 36.1%.
Strategic focus on healthcare, especially dental, and industry turnaround drove margin improvements and outperformance versus market.
Growth and Efficiency program delivered CHF 22.6m in savings over 2024/2025, with CHF 4.3m already secured for 2026.
Recognized by TIME Magazine as one of the world's best companies in sustainable growth for 2026.
Leadership changes included appointment of new CFO Sven Luginbühl and new Beauty business unit head Jennifer Dean.
Financial highlights
Group revenues at CHF 448.0m, down 4.8% organically and 7.4% reported year-over-year.
Gross profit margin increased 310 bps to 36.1%, gross profit up to CHF 161.9m.
Adjusted EBITDA reached CHF 89.7m (20% margin), above guidance; reported EBITDA CHF 78.3m (17.5% margin), up 5.1% year-over-year.
EBIT increased 76.7% to CHF 22.8m, with EBIT margin up to 5.1%.
Free cash flow was CHF 27.1m, down 31.7% year-over-year; operating net cash flow declined to CHF 40.3m.
Outlook and guidance
2026 guidance: flat to low single-digit organic revenue growth, adjusted EBITDA margin around 20%.
Midterm revenue CAGR remains above 4%, with adjusted EBITDA margin guidance raised to above 21%.
H2 2026 expected to be stronger due to new product launches; dual sourcing impact in drug delivery to subside by year-end.
Dividend policy updated: minimum 40% of EPS to be distributed, with higher payout possible based on performance and liquidity.
- Profitability rose above guidance on cost savings, with margin outlook maintained despite lower sales.MEDX
H1 20253 Feb 2026 - Revenue and cash flow improved sequentially, but 2024 guidance was revised down amid soft demand.MEDX
H1 20243 Feb 2026 - Profitability and cash flow improved; CHF 30M cost-saving program and mid-term growth targets set.MEDX
H2 202423 Dec 2025
Next Medmix earnings date
Next Medmix earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage